Search for: "FOREST PRODUCTS V US" Results 201 - 220 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2022, 6:53 pm by Lawrence B. Ebert
Cir. 2022), and any sub sidiary fact findings about extrinsic evidence for clear er ror, Forest Labs., LLC v. [read post]
8 Mar 2008, 5:06 pm
British Columbia Forest Products Ltd. (1986), 5 B.C.L.R. (2d) 1 (C.A.), per Esson J.A. dissenting, at pp. 10-11. [read post]
14 May 2018, 1:51 pm by Ashley Remillard
The areas are part of a forest actively managed for timber production, and the owners (Petitioners) have no intention of restoring the characteristics that could support the frog. [read post]
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Istodax (Romidepsin) – US: False marking complaint filed concerning Istodax products: Promote Innovation LLC v. [read post]
10 May 2024, 9:00 am by Public Employment Law Press
[FN1] Thereafter, the LGPC submitted permit applications and supporting materials for the use of ProcellaCOR in both bays. [read post]
10 May 2024, 9:00 am by Public Employment Law Press
[FN1] Thereafter, the LGPC submitted permit applications and supporting materials for the use of ProcellaCOR in both bays. [read post]
20 May 2011, 2:37 pm
When I was a kid in the early 70's in New York, malcontents acted out in tried and true ways.... like spraying Nair, the hair removal product in a can, on the heads of us happy-go-lucky little Trick-or-Treaters on Halloween. [read post]
14 Nov 2009, 5:59 am by Rebecca Tushnet
(This doesn't seem to go to sponsorship of communications v. sponsorship of products and services.) [read post]
15 Jun 2011, 11:12 am by Michelle Yeary
              At issue in United States v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
4 Aug 2010, 12:21 am by Kelly
(Patent Docs) Namenda (Memantine) – US: Forest and Merz Pharma settle Namenda infringement dispute (Patent Docs) Naropin (Ropivacaine) – US: Patent infringement complaint filed following ANDA filing: APP Pharmaceuticals, LLC v. [read post]